Clinical Trial: Rapid Immune Modulating Effects
NCT07195552 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2025-09-26
Summary
The goal for this clinical trial is to compare the immune effects of three different medicinal mushrooms to a placebo. The mushrooms include Agaricus, Reishi, and Turkey Tail.
Conditions
- Immune Surveillance
Interventions
- DIETARY_SUPPLEMENT
-
Agaricus blazei
Agaricus blazei mushroom capsules. 2000 mg per serving
- DIETARY_SUPPLEMENT
-
Reishi
Reishi mushroom capsules. 2000 mg per serving.
- DIETARY_SUPPLEMENT
-
Turkey Tail
Turkey tail mushroom capsules. 2000 mg per serving.
- OTHER
-
Placebo
Placebo
Sponsors & Collaborators
-
Natural Immune Systems Inc
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-07-01
- Primary Completion
- 2025-11-30
- Completion
- 2025-12-31
Countries
- United States
Study Locations
More Related Trials
-
The Role of Interferon-gamma in Immune Responses to Invasive Candidiasis
NCT05235711 ·Status: COMPLETED
-
Caspofungin Study for Fungal Infections in Adults in Critical Care Settings
NCT00095316 ·Status: TERMINATED ·Phase: PHASE3
-
ImPACt on Invasive Fungal Infections by Immune Checkpoint Inhibition
NCT04533087 ·Status: COMPLETED
-
Itraconazole for the Prevention of Fungal Infections in Chronic Granulomatous Disease
NCT00001280 ·Status: COMPLETED ·Phase: PHASE2
-
Studies of Disorders With Increased Susceptibility to Fungal Infections
NCT01222741 ·Status: RECRUITING
-
Study of Innate Host Immune Response to C. Glabrata Clinical Isolates Resistant to Echinocandins: Impact on the Management of Candidemia in High-risk Patients
NCT03652194 ·Status: UNKNOWN
-
Fungal Infection Susceptibility
NCT00001352 ·Status: RECRUITING
-
Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems
NCT00238355 ·Status: TERMINATED ·Phase: PHASE2
-
An Efficacy and Safety Study of Itraconazole Sequential Therapy (Intravenous Injection Followed by Oral Solution) in Invasive Pulmonary Fungal Infections
NCT01823289 ·Status: COMPLETED ·Phase: PHASE4
-
TMC125-TiDP2-C187: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-state in Healthy Subjects.
NCT00740389 ·Status: COMPLETED ·Phase: PHASE1
-
Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant
NCT01503515 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Candida Eradication and Serum Cidal Activity of Echinocandins
NCT00839540 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy Of Itraconazole In Chronic Cavitary Pulmonary Aspergillosis
NCT01259336 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Investigate the Effect of Itraconazole on the Way the Body Absorbs, Distributes, and Gets Rid of ACT-1004-1239 Given as a Single Dose of 10 mg to Healthy Male Subjects
NCT05549531 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Compare Efficacy and Safety of Mycamine® and Itraconazole for Preventing Fungal Infections
NCT00794703 ·Status: COMPLETED ·Phase: PHASE3
-
Comparing the Efficacy of Oral Fluconazole Versus Oral Itraconazole in Treating Resistant Tinea Corporis
NCT07342153 ·Status: RECRUITING ·Phase: PHASE4
-
A Study of Fluconazole in the Prevention of Fungal Infections in HIV-Infected Patients Living in Areas Where Fungal Infections Are Common
NCT00002325 ·Status: COMPLETED ·Phase: NA
-
A Study to Learn About How Itraconazole Affects the Blood Level of Study Medicine (PF-07817883) in Healthy Adults.
NCT05822440 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Blastomycosis Dermatitidis Infection in Patients Not Infected With HIV and Complications Associated With Blastomycosis Dermatitidis Infection
NCT00001702 ·Status: COMPLETED
-
A Study to Examine the Efficacy and Safety of Posaconazole When Introduced Early in the Treatment of Refractory Fungal Infections (P05090 AM2)
NCT00550732 ·Status: COMPLETED ·Phase: PHASE2
-
Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant Recipients
NCT00841971 ·Status: COMPLETED ·Phase: PHASE4
-
Detecting Infections Rapidly and Easily for Candidemia Trial (DIRECT)
NCT01525095 ·Status: COMPLETED
-
Efficacy and Safety of Amphotericin B and Azoles in the Treatment of Invasive Fungal Disease
NCT06819410 ·Status: RECRUITING
-
A Randomized, Open, Comparative Multicenter Study of Initial Treatment With Intravenous Itraconazole Versus Amphotericin B Followed by Consolidation Treatment With Itraconazole Capsules in Patients With Blastomycosis or Histoplasmosis
NCT00002159 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Aspergillus Fumigatus (a Fungal Infection) in Patients With Cystic Fibrosis
NCT00528190 ·Status: COMPLETED ·Phase: PHASE4